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Abstract
Purpose We investigated the added value of a new
respiratory amplitude-based PET reconstruction method
called optimal gating (OG) with the aim of providing
accurate image quantification in lung cancer.
Methods FDG-PET imaging was performed in 26 lung
cancer patients during free breathing using a 24-min list-
mode acquisition on a PET/CT scanner. The data were
reconstructed using three methods: standard 3D PET,
respiratory-correlated 4D PET using a phase-binning
algorithm, and OG. These datasets were compared in terms
of the maximum SUV (SUVmax) in the primary tumour
(main endpoint), noise characteristics, and volumes using
thresholded regions of SUV 2.5 and 40% of the SUVmax.
Results SUVmax values from the 4D method (13.7±5.6)
and the OG method (14.1±6.5) were higher (4.9±4.8%, p<
0.001 and 6.9±8.8%, p<0.001, respectively) than that from
the 3D method (13.1±5.4). SUVmax did not differ between
the 4D and OG methods (2.0±8.4%, p=NS). Absolute and
relative threshold volumes did not differ between methods,
except for the 40% SUVmax volume in which the value
from the 3D method was lower than that from the 4D
method (−5.3±7.1%, p=0.007). The OG method exhibited
less noise than the 4D method. Variations in volumes and
SUVmax of up to 40% and 27%, respectively, of the
individual gates of the 4D method were also observed.
Conclusion The maximum SUVs from the OG and 4D
methods were comparable and significantly higher than that
from the 3D method, yet the OG method was visibly less
noisy than the 4D method. Based on the better quantifica-
tion of the maximum and the less noisy appearance, we
conclude that OG PET is a better alternative to both 3D
PET, which suffers from breathing averaging, and the noisy
images of a 4D PET.
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Introduction
Accurate delineation of tumour lesions in lung cancer
based on PET/CT is required in radiotherapy treatment
planning. Moreover, as the amount of
18F-fluorodeox-
yglucose (FDG) uptake is prognostic for survival, precise
measurement of the standardized uptake value (SUV) may
be of clinical value [1–3]. However, delineation of lung
tumours is fraught with error and suffers from significant
inter- and intraobserver variability [4, 5]. Tumour defini-
tion based on FDG-PET/CT is the current standard, but the
method is far from ideal [6–9]. In particular, the FDG
uptake pattern in 3D PET imaging suffers from breathing
averaging, which prevents accurate SUV and volume
measurements.
Respiratory-correlated PET imaging (4D PET) is an
attractive alternative [10–15]. In 4D PET, a surrogate
measurement of the patient’s breathing is made during the
scan, and based on this information the PET data are sorted
according to respiratory phase or amplitude. Hybrid methods
have also been proposed [16]. Phantom studies have shown
that 4D PET predicts lesion volume recovery more accu-
rately than 3D PET and yields more accurate SUV values
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DOI 10.1007/s00259-010-1716-6[17–22]. In spite of its promise, 4D PET has had limited
clinical acceptance. Perhaps the most significant limitation is
the technical challenge of making the respiratory measure-
ment in a clinical setting, handling the large amount of 4D
data, and applying the respiratory motion information in
treatment planning. Moreover, 4D PET images have rela-
tively more statistical noise than 3D PET images, since only
a fraction of the acquired data is used in each image. There is
concern about inconsistent attenuation correction in 4D PET
due to mismatches between PET and CT [23]. Even if 4D
CT is used for attenuation correction of the corresponding
4D PET, errors due to the mismatch of CT and
corresponding PET gates may be introduced due to differ-
ences in the binning methods used for reconstructing 4D CT
and 4D PET [24]. Despite its drawbacks, 3D PET is still
used for tumour delineation and characterization of tumours
and lymph nodes.
In this study evaluated a new method, optimal gating
(OG), for applying respiratory-correlated measurements to
PET. OG finds a single amplitude interval which minimizes
the blurring due to respiratory motion while maximizing the
number of coincidence events. We compared 3D, 4D and
OG PET in terms of SUV, tumour volume and noise.
Materials and methods
Patient overview and PET acquisition
An FDG-PET scan was performed in 26 patients with lung
cancer treated in the period between August 2008 and March
2009. The scan was performed during free breathing using a
Siemens Biograph 40 PET/CT scanner (Siemens Medical
Solutions, Knoxville, TN, USA) for radiotherapy treatment
planning purposes. Patients were positioned supine with a
dedicated arm support in the radiotherapy position. Our
standard clinical protocol included a 4D CT scan and a 24-
min list-mode PET acquisition of a single bed position
(16.2 cm axial extent) centred on the primary tumour. The
signal was measured using a respiratory monitor system
(RMON) with a pressure sensor in a belt strapped around the
patient’s chest (AZ-733 V; Anzai Medical Corporation,
Tokyo, Japan) [25, 26]. The injected activity (megabec-
querel) of FDG depended on the weight (kilograms) of the
patient and for the first nine patients in the study was four
times the body weight plus 20 MBq. For the second set of 17
patients, the injected activity was 2.5 times the body weight
following the recommendations of Boellaard et al. [27].
3D, 4D and OG PET image reconstruction
The list-mode data were reconstructed using three methods:
(1) standard 3D PET reconstruction, resulting in a free-
breathing PET image for a 24-min acquisition; (2) phase-
based 4D PET reconstruction, with eight gates; and (3)
reconstruction using the OG algorithm.
The OG PET reconstruction was applied after processing
the respiratory signals, s(t), acquired during the scan.
Prototype software, described in Appendix A was used to
create a modified PET data list with the motion largely
removed, and this modified list was processed normally on
the clinical PET/CT system. The first step in the OG
method is to form a histogram of the s(t) values. Second,
the histogram is converted to a cumulative distribution
function, cdf(s), representing the probability of observing a
signal of amplitude s or greater. Third, an algorithm
considers all possible combinations of lower (L) and upper
(U) levels, subject to a constraint on U that forces the total
sensitivity to equal a specific percentage (e.g. 35%) of the
acquired breathing signals. The specific percentage is a
parameter that is called the optimal gating yield parameter,
OGyield. The constraint can be written as:
cdf ðUÞ cdf ðLÞ¼OGyield ð1Þ
To emphasize that this is a parameter, we write:
OGyield ¼ 0:35: ð2Þ
A rationale for choosing the specific value of 0.35 is
presented in Appendix B. The OG method determines the
narrowest such interval by selecting the L value which
makes the difference U – L as small as possible. In most
patients, the result is a narrow range of breathing
amplitudes near the end-expiration phase. Figure 1 shows
a 30-s plot of breathing amplitudes in a representative
patient study, along with the histogram from the entire 24-
min acquisition. The optimal amplitude interval is repre-
sented by a shaded region representing a range of breathing
amplitudes, or alternatively a portion of the histogram.
For all PET image reconstructions, attenuation correction
was performed using the maximum exhalation phase of the
4D CT scan. In most patients, this is the most representative
phase. For some patients 4D CT images were not available at
themaximumexhalationphase.InthesecasesweusedtheCT
phase closest to maximum exhalation. Reconstructions were
performed using a Fourier-rebinning-based OSEM 2D algo-
rithm with four iterations and eight subsets, witha final image
size of 168×168 pixels with a typical pixel size of
approximately 4 mm and a 3-mm slice thickness.
Phantom validation
To validate the OG PET reconstruction we performed a
phantom study. We used a sphere with a diameter of
approximately 3.2 cm and volume of 17 cm
3 filled with 10
MBq of FDG that was mounted on a motorized platform
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Japan). The RMON pressure sensor was attached to the
platform to monitor the motion. The sphere moved at a rate of
ten cycles per minute on a trajectory with an amplitude of
1.7 cm. The period and the amplitude of the motion
correspond to the movement of lung tumours in vivo. A 10-
min acquisition time was used for these experiments. Signal
quality was veryhigh because the sourcewas strongand there
was little attenuating medium around the phantom. A 4D CT
scan was also acquired. In a similar manner to the PET
reconstructions for the patients, 3D, 4D and OG PET
reconstructions were performed. The average over all eight
gates of the 4D PET measurements was used as the reference
value to which the other reconstructions were compared.
Analysis of PET images
PET images of the patients were analysed using TrueD
software (version VC60; Siemens, Erlangen, Germany). For
all ten datasets, i.e. the 3D PET dataset, the 4D PET dataset
with eight gates and the OG PET dataset, the volume of
interest (VOI) was selected manually in the transverse,
sagittal and coronal anatomical planes around the primary
tumour. This VOI was carefully selected so as not to
include any high FDG uptake regions of nonprimary
tumour tissue such as the heart or the involved mediastinal
lymph nodes. In the VOI the threshold for volume
calculation was based on two autocontouring criteria: first,
a fixed SUV threshold of 2.5 [28], and second, a relative
threshold of 40% of the maximum SUV (SUVmax) in the
primary tumour [8, 29]. We recorded the volume of the
region to which the threshold was applied, and the
minimum, average, maximum and standard deviation of
SUV values inside the region.
To provide a measure of image noise, we created an
additional VOI in the contralateral lung, selecting a region
that appeared to be homogeneous. This VOI was copied to
all datasets, and the standard deviation of the SUV values
was computed and recorded as a fraction of the mean value
in the VOI.
In addition, the displacement of the centre of mass of the
SUV volumes in each of the corresponding gates of the 4D
PET was automatically calculated in three dimensions by
the TrueD software. A 3D motion vector, defined as the
square root of the quadratic sum of motion amplitudes in
the transverse, sagittal and coronal directions, was deter-
mined for each patient.
Evaluation strategy
Our hypothesis was that OG would produce less blur than
3D reconstruction and less noise than 4D reconstruction,
and yet be quantitatively accurate. The most important
objective in the analysis was to retrieve quantitative values
for the maximum SUV inside the primary tumour. Because
a gold standard was missing, we chose the average of the
maximum SUV in the 4D PET as the reference. As a
secondary objective, we quantified differences in the
volume as determined by different reconstruction methods
and different delineation criteria. Finally, noise in the
images was evaluated to give an objective surrogate for
image quality.
Statistical analysis
Paired variables were compared using a Wilcoxon Signed
Rank’s test (Matlab R2009a; The Mathworks, Natick,
MA). Because a Bonferroni correction was applied to
Fig. 1 Example breathing pattern (left) over 30 s showing the optimal
gating window. The histogram (right) shows the amount of breathing
amplitudes for the entire 24-min list-mode acquisition. The OG
method selects the narrowest bandwidth (shaded area) containing
35% of the respiratory signal
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performed in this analysis), p values obtained from
statistical testing were multiplied by 3. P values smaller
than 0.05 were assumed to be statistically significant.
Results are expressed as means ± standard deviation,
unless mentioned otherwise.
Results
Phantom experiment
Figure 2 shows coronal sections through 4D, 3D, and OG
images from the phantom experiment. The 3D PET image
was visibly blurred, whereas the OG image appeared to be
as sharp as the 4D images. Quantitative differences in
maximum pixel value were similar in all measurements.
Compared to the average over all phases of the 4D PET
dataset, the 3D image was 1.2% lower and the OG image
was 1.2% higher. The variation in SUVmax within the 4D
acquisition was 1.5%. The volumes were compared by
computing autothresholded volumes using the 40% of the
maximum SUV criterion. The volume in 4D PET was 15.8
±0.3 cm
3, averaged over phases. The volume in 3D PET
was 13.8 cm
3. The volume in OG PET was 15.1 cm
3.
Average SUVs within autothresholded volumes varied by
4.7% across gates in the 4D PET acquisition, and in OG
PET the average SUV was 3.4% higher. In 3D PET, the
average SUV was 10.2% lower.
Patient characteristics
Table 1 shows the patient characteristics. The average
length of the motion vector in 3D of the primary lung
tumour of the 26 patients was 3.8±2.7 mm, with a range
between 1.3 and 11.3 mm. Examples of the 3D, 4D and OG
PET images are shown in Fig. 3.
SUVmax values
Table 2 compares average SUVmax values in the primary
tumours. The maximum values for the 3D, 4D and OG PET
reconstruction methods were 13.1±5.4, 13.7±5.6 and
14.1±6.5, respectively. The large standard deviations were
caused by the large interpatient variability and SUVmax
ranges from approximately 5 to 35. The SUVmax values
for the 3D PET method were significantly lower than the
values for the 4D and OG methods. The differences were
4.9±4.8% (p<0.001) lower than the 4D values, and 6.9±
8.8% lower than the OG values (p<0.001; Table 3). The
average SUVmax values for the OG and 4D methods were
similar, the differences being 2.0±8.4% (p=NS). Individual
SUVmax values are shown in Fig. 4.
Differences were observed between the SUVmax of the
different gates of the 4D PET images. In several cases,
these variations exceeded 10%; this is shown in Fig. 5. The
standard deviation of the SUVmax values within the
individual patients, expressed as ratios in relation to the
mean 4D PET value, was 4.0±2.1% for the entire patient
population, ranging from 1.9% (patient 19) to 12.7%
(patient 17). In the case of patient 17, the SUVmax ranged
from 6.8 to 10.0 with a median value of 7.7 for a small
tumour of 1.7 cm
3.
Fixed SUV threshold
The volumes computed with autocontours at a fixed
threshold of 2.5 SUV were not significantly different
between the three methods (the differences were of the
order of 1 cm
3): 74.2±76.8 cm
3, 75.1±77.9 cm
3 and 74.9±
76.2 cm
3 for the 3D, 4D and OG methods, respectively.
The average SUV values in the volume within the contour
were 5.4±1.2, 5.4±1.1 and 5.6±1.3, and the values from
both the 3D and 4D methods differed slightly, but
significantly (p<0.001), from the average OG PET values.
Relative SUV threshold
Volumes computed by the 40% thresholding criterion did
show significant differences between the 3D and 4D
methods, but otherwise no significant differences were
seen. This is shown in Table 2. A significant reduction of
5.3±7.1% (p=0.007) in the average 4D volume compared
to the 3D volume was found, although the average absolute
numbers were all within 2 cm
3. Figure 5 shows the
variation in autothresholded volumes for the different gates
of the 4D reconstruction. As an example, considering all
gates for patient 17, the volumes determined by the 40%
SUVmax method in this dataset varied between 61% and
139% of the mean volume. The average SUV values within
the 40% SUVmax contour were 7.8±3.1, 8.1±3.2 and 8.4±
3.8, for 3D, 4D and OG methods, respectively. Again,
average values for the 3D method differed significantly
from those for the OG and 4D methods, whereas there was
no significant difference between the values for the OG and
4D methods.
Fig. 2 Phantom experiment
showing 4D PET reconstructed
images together with the motion
blurred (static) 3D PET and the
OG PET images
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For the evaluation of image noise based on the contralateral
lung, VOIs with an average size of 37.8±18.5 cm
3 were
created. The standard deviations of the SUV values of the
VOI inside the contralateral lung are shown for all patients
in Fig. 6. Compared to the 3D PET method, the noise was
higher for the 4D PET method (89±52%, p<0.001) and the
OG PET method (31±21%, p<0.001). Noise for the OG
PET method was 44±30% (p<0.001) lower than that for
the 4D PET method.
Discussion
Accurate quantification of FDG uptake is important in
oncology. PET imaging is used for staging and diagnosis of
lung tumours, for quantifying the SUV, and for delineating
the actual border of the tumour. For conventional radio-
therapy schemes, a better delineation of the primary tumour
will in general lead to smaller safety margins used in
radiotherapy to define the treated volume. These smaller
irradiated volumes will encompass less normal lung tissue
Characteristic Value
Gender
Male 16
Female 10
Age (years)
Median 67
Range 55–83
Cancer type
NSCLC 14
SCLC 2
NSCLC stage
I/II 4
IIIA 8
IIIB 8
IV 4
Location of primary tumour
Left upper lobe 8
Left lower lobe 3
Right upper lobe 6
Right lower lobe 7
Central 2
Table 1 Patient characteristics
Fig. 3 Axial images from an
example patient (patient 18)
comparing OG, 3D and 4D PET
reconstruction methods: top row
CT images, middle row PET
images, bottom row fused PET/
CT images; left column OG
reconstruction, middle column
3D reconstruction, right column
4D reconstruction
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isotoxic dose-escalation strategy is used this will lead to a
higher tumour dose and hence higher overall survival in
lung cancer patients [30]. Delineating subvolumes of the
tumour are currently also a focus of research, as areas with
high SUV are presumably more therapy-resistant [2, 31,
32]. Especially in the context of more advanced radiother-
apy techniques that rely on dose painting or subvolume
boosting strategies, accurate quantification of the PET
uptake is essential to define these regions. Furthermore,
accurate quantification becomes more important in current
trials and clinical practice. In a large Dutch randomized trial
(NVALT 8), patients were randomized between two
treatment arms based on a SUVmax cut-off value of 7.
Applying this to the cohort of patients analysed in this
study would mean an increase of approximately 10% in the
number of patients in the SUVmax >7 group if 4D or OG
PET was used for quantification.
Validation of automatic segmentation methods and
delineations in patients with lung cancer is difficult. Results
from pathological studies are limited and hampered by
technological difficulties in specimen extraction from
thoracic surgery [4, 5]. Hence, a gold standard for tumour
delineation is difficult to obtain [33]. Validation of new
PET reconstruction methods for accurate SUV quantifica-
tion techniques in vivo is also not directly possible and is
limited to phantom evaluations and validation. We therefore
performed a phantom validation, demonstrating correct
technical behaviour of the optimal gating method providing
confidence that the method is applicable in a clinical
setting. The phantom movement was similar, even slightly
smaller, compared to the size. Hence, no large differences
in SUVmax were expected for these reconstructions. The
volume recovery of the 3D PET reconstruction differed
from that of the 4D PET reconstruction, whereas that of the
OG PET method was similar. However, the images in Fig. 2
clearly show that either the 4D or OG PET reconstruction
methods was necessary to reduce blurring artefacts from
respiratory motion. Figure 2 also shows the correct
processing of the list-mode files and OG PET reconstruc-
tion technique.
The prototype software was expected to be quantita-
tive in the case of regular breathing, as described in
Appendix A. The prototype software treated the OG
sinogram as if it came from a static acquisition, and
therefore could not accurately correct for effects that are
correctly modelled in 4D PET, for example changes in
activity distribution during the scan, detector dead time,
and decay of the radioisotope. In spite of this limitation, in
most scans the quantitative values (SUVmax) were similar
for the OG and the average of the 4D method. Figure 4
demonstrates the close agreement and supports our
hypothesis that motion blurring would be reduced by OG
and that it is possible to extract accurate quantitative
values from the OG method. In 3D PET, the SUVmax was
significantly reduced due to respiratory motion blurring.
Table 2 Results of the 3D, 4D and OG PET reconstruction: maximum SUV, and volumes within the SUV 2.5 and 40% of the SUVmax cut-off
(values are means±SD)
VOI Parameter 3D 4D
a OG
n.a. Maximum SUV 13.1±5.4 13.7±5.6 14.1±6.5
40% of SUVmax Average SUV 7.8±3.1 8.1±3.2 8.4±3.8
Volume (cm
3) 32.2±32.9 30.1±29.6 31.4±32.2
SUV>2.5 Average SUV 5.4±1.2 5.4±1.1 5.6±1.3
Volume (cm
3) 74.2±76.8 75.1±77.9 74.9±76.2
aThe 4D values are the averages over all eight gates of the dataset.
Table 3 Differences between maximum SUV, volumes within the SUV 2.5 and 40% of the SUVmax cut-off for the 3D, 4D and OG PET
reconstruction
VOI Parameter Difference 3D vs. OG PET (%) Difference 4D vs. OG PET (%) Difference 3D vs. 4D PET (%)
Mean±SD p value Mean±SD p value Mean±SD p value
n.a. Maximum SUV 6.9±8.8 <0.001* 2.0±8.4 1.271 4.9±4.8 <0.001*
40% of SUVmax Average SUV 6.4±9.7 <0.001* 2.7±8.3 0.547 3.5±4.1 0.001*
Volume (cm
3) −0.8±9.0 0.102 5.3±12.3 0.220 −5.3±7.1 0.007*
SUV>2.5 Average SUV 3.4±4.8 <0.001* 2.8±3.8 0.001* 0.6±1.8 1.271
Volume (cm
3) 3.6±7.1 0.355 2.5±6.3 2.195 1.0±3.4 0.175
*p<0.05.
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determining the SUVmax for the 4D phase-based PET
reconstruction we used. Choosing an amplitude-based
binning approach might reduce the variation to some
extent by reducing the residual motion component, but the
counts in each gate would vary and lead to different
statistics for the various gates. For the volumes delineated
using 40% of the SUVmax, the values from the 4D
method were smaller. There could be several reasons for
this. Accurate determination of SUVmax of the individual
phases was hampered due to increased noise leading to a
somewhat larger SUVmax whi c hr e s u l t e di ns m a l l e r
delineated volumes. Another possibility could be that the
volume of the tumours in this study were quite large and
motion was limited for these tumours, making volume
definition in 3D already a good estimate of the actual
volume of the lesion. For smaller tumours and in the case
of more respiratory motion this might be different.
However, our dataset was too limited to draw definite
statistical conclusions.
Fig. 4 SUVmax values for the
OG, 3D and 4D PET recon-
struction methods classified
according to tumour location
inside the lung
Fig. 5 Top row: box plot of the
SUVmax values normalized to
the mean value for the different
gates of the 4D PET method.
Bottom row: box plot of the
volumes defined by 40% of the
SUVmax normalized to the
mean volume for the individual
patients. In both plots, the edges
of the boxes represent the 25th
and 75th percentiles, and the
whiskers represent the extreme
data points. Outliers are plotted
individually (circles)
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gated 4D PET images, and not as noisy. Since image
quality is difficult to quantify directly in absolute
numbers, we used a surrogate of noise defined as the
standard deviation of the SUV in a homogeneous part of
the lung, and this clearly showed reduced noise for OG
PET compared to 4D PET. Also, OG PET images were
visually sharper at the border of the primary tumour
(Fig. 3) compared to the 3D PET images which had
intrinsic motion blurring. The average motion of the
primary tumour was about 4 to 5 mm which was
comparable to the resolution and voxel size of the PET
scanner. Some deterioration of the edges of the primary
tumour was visible in the static 3D PET images.
Noise in the 4D PET images was also reflected in the
variations between the various gates of the 4D reconstruc-
tion. Volume differences up to 40%, and differences as
large as 27% in maximum SUV were shown in this study.
These results were similar to variations reported by Erdi et
al. [23]. These effects might be partly caused by a wrong
attenuation correction due to a mismatch between the CT
and PET scan [22]. Using the end-expiration phase of the
4D CT would be expected to minimize the errors caused by
the attenuation correction. In patients who breathe normal-
ly, end-expiration is the most stable breathing phase. In our
experience, the OG algorithm typically found an amplitude
interval range near to that of the end-expiration phase. One
could prospectively gate the CT scanner to acquire
attenuation data at the respiratory amplitude determined
by the OG calculation, and the patient would receive very
little additional radiation exposure from the prospectively
gated CT scan. This was not possible in the retrospective
study described here. For patients with an irregular or
nonphysiological breathing pattern, choosing a different CT
gate for the attenuation correction might circumvent
possible errors in attenuation correction. However, for the
patient group described in this study all OG amplitude
intervals were close to the end-exhale position.
Others have tried breath-hold techniques for motion
freezing, mainly for the CT acquisition [34, 35]. For PET
imaging, breath hold techniques might not be feasible
because the patient needs to breath-hold repeatedly, because
acquisition times are typically in the order of minutes,
whereas the CT scan can generally be performed in a few
seconds. Reproducibility of the breath-hold phase for
multiple breath holds is difficult, and may require specially
designed equipment. The approach described in this paper
is simple, and comfortable for the patient as free breathing
is allowed during the scan. If 4D images are not required
for evaluation of the tumour motion, and OG images are to
be used instead, the duration of the study can be
significantly reduced, further increasing patient comfort.
The simplicity of the OG method is expected to make it
comparatively robust. This simple method may not be able
to recover all of the resolution possible with a PET scanner.
It is our view that better resolution imaging might one day
be achievable with accurate modelling of the complex
motions that occur during human breathing, perhaps using
methods such as optical flow-based methods of Dawood et
al. [36]. In Appendix B we show that OG reduces the
blurring from 1 to 2 cm, in extreme cases, to the range 6 to
7 mm that is normal in PET imaging today. Indeed, the OG
methodology should work well in the imaging of small
tumours, for example metastatic lesions. In such cases, the
motion trajectory may exceed the size of the tumour.
Another improvement of the OG method compared to 3D
and 4D PET would be the detection of involved lymph
nodes in the mediastinum. The OG PET might reveal these
nodes whereas for the 3D PET these might be blurred due
to motion and the 4D PET contains too much noise to
distinguish them from the surrounding uptake. However,
this has to be validated in clinical practice. Similarly, the
Fig. 6 Standard deviations of
the SUV values inside the VOI
in the contralateral lung tissue
for all patients relative to the
value of the 3D PET
reconstruction
850 Eur J Nucl Med Mol Imaging (2011) 38:843–855OG method is also applicable in cardiac imaging, where
respiratory motion is in many cases larger in magnitude than
the heart’s contractile motions. Indeed, Frey et al. have
recently reported examples in which the OG method
significantly sharpened the images in tumour imaging and
cardiac PET/CT, with better image quality than 4D PET [37].
However, motion amplitude of the primary tumour is
difficult to predict and selection of 3D vs. 4D PET
acquisition is frequently not possible prior to the imaging
session. The OG reconstruction might be the intermediate
step suitable for all patients providing good signal-to-noise
ratios for quantitative analysis of the SUV parameters and
sharp (non-motion-blurred) images for visual assessment.
Conclusion
The SUVmaxfor the OG and4DPETreconstructionmethods
were comparable and were both significantly higher than that
for the 3D PET reconstruction method. Optimal gating
accurately determined the SUVmax values, while reducing
image noise and providing accurate volume determination,
comparable to that from 3D and 4D PET. Based on the better
quantification of the maximum value and the less noisy
appearance, we conclude that OG PET is a better alternative
both to 3D PET, which suffers from breathing averaging, and
to 4D PET, which produces noisy images.
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Appendix A. Formation of respiratory gated images
The data flow for ordinary 4D PET is illustrated in Fig. 7a.
A respiratory monitor system (RMON) analysed the
respiratory amplitude waveform s(t) from the patient in
near-real time and provided a logic pulse, or trigger,
whenever the patient’s breathing reached a specified point
in the breathing cycle. Typically, we set the system to
provide triggers at 100% inspiration. The triggers were
communicated to the PET scanner, which recorded these as
gates in the list-mode file, along with other information
needed for quantitative PET. A reconstruction computer
converted the list to static (3D) images and 4D images.
Amplitude-based reconstructions were performed by mod-
ifying this system in a prototype configuration of computers
and software, illustrated in Fig. 7b. The RMON included a
computer that recorded the waveform, the triggers, and
timing information relative to the start of the respiratory
acquisition (clock 2) in a separate respiratory data list file.
These data and the PET data list were communicated to an
auxiliary computer which converted them to a new optimally
gated (pruned) data list, which was sent to the reconstruction
computer to create the optimally gated image.
Clock 1 in the PET list and clock 2 in the respiratory
data list ran at the same rate but were offset from one
another by a time offset Δt. In each patient study, we
determined Δt by digital calculation. Since the RMON was
configured with a 0.025-s time resolution and the PET
scanner had a 0.001-s time resolution, we defined two
arrays in computer memory representing 0.025-s samples of
the trigger signals in the RMON (the T array) and gate
signals in the PET scanner (the G array). A value of 1
represented intervals in which the trigger or gate was on,
and 0 represented intervals in which the trigger or gate was
off. The length of each array represented a time interval at
least twice as long as the acquisition time. Array indices
represented the time from the beginning of the recorded
information. Figure 7c shows the triggers and gates and
their relation to the waveform. Alignment of the two clocks
was based on aligning triggers with gates. This was
analogous to matching fingerprints and used a technique
that, like fingerprint matching, was robust in the case of
missing data points. The correlation of T and G was:
c Δt ðÞ ¼ TðtÞ Gt  Δt ðÞ hi ; ðA:1Þ
where ‹…› represents averaging. We calculated this with an
approach based on the Fourier shift theorem [38]:
c Δt ðÞ ¼ F 1 FðTÞ FðGÞ
»   
; ðA:2Þ
where F is the discrete Fourier transform, F
−1 is its inverse,
and the asterisk represents complex conjugation. The
correlation function for this patient study is shown in
Fig. 7d. A sharp, prominent maximum defined the actual
time offset. This can be expressed by the equation:
Δtactual offset ¼ argmax c Δt ðÞ fg ðA:3Þ
The plot also shows broad peaks representing harmonics.
When the gates were temporally shifted by Δtactual offset,
they were perfectly aligned with the triggers, as shown in
Fig. 7e.
With the temporal relation between RMON and PET
determined in this way for each patient study, we created
the new optimally-gated PET data list using a program in
the auxiliary computer. Event words from the PET scanner
were included in the new list whenever the amplitude fell
between the L and U thresholds defined in Materials and
Methods. Other events were discarded. The new list
contained the optimally gated part of the original list, about
35%, and represented the conditions of a static study in
Eur J Nucl Med Mol Imaging (2011) 38:843–855 851which the data rate was 100% when s(t) was in range, and
0% when it was out of range. The program recorded the
total time, Tin range when the signal was in range, which
could be compared to the total time of the acquisition, Tacq.
The reconstruction computer created a nonquantitative
static image. The images were multiplied by the ratio Tacq
/Tin range to make them more nearly quantitative. This
simple scaling approach would be accurate in the case of a
constant breathing pattern during the PET acquisition, with
the optimal gate opening and closing regularly during the
scan, resulting in a simple data loss of Tacq /Tin range.A n
irregular breathing pattern would result in more data being
Fig. 7 Processing for respiratory gating. a Data flow in ordinary 4D
PET. b Data flow with amplitude-based respiratory gating. c A 60-s
trace showing gates before synchronization, triggers, and respiratory
amplitudes. d Time correlation between triggers and gates. e Gates
and triggers after synchronization
852 Eur J Nucl Med Mol Imaging (2011) 38:843–855acquired at the beginning or end of the scan, leading to
quantitative errors.
Appendix B. Rationale for choosing the optimal gating
yield parameter
The optimal gating algorithm has only one parameter, the
yield parameter, which was set to OGyield=0.35, or 35%.
We determined several years ago that this value is
appropriate because most patients pause between breaths,
representing about one-third of the breathing cycle. We
believed that in most cases an analysis of a patient’s
breathing pattern should find the quiescent part of the
breathing cycle. The shaded band in Fig. 1 is a typical
example.
In addition, a physics-based argument demonstrates that
35% is an appropriate choice. We assume that the tumour
moves in a definite direction, say z, and that the position
relative to a reference point is proportional to s(t) described
in Materials and methods. The position at time t is:
zðtÞ¼zref þ k   sðtÞ; ðB:1Þ
where k is a proportionality constant. Since one does not
know the actual motion at any point in the chest, we
assume a nearly worst-case scenario. We assume that the
tumour excursion is 30 mm except for the lowest 2% and
the highest 2% of the amplitudes seen in s(t). To make this
concrete, we refer to the histogram h(s) and the cumulative
distribution cdf(s) described in Materials and methods. Let
a2 and a98 be the amplitudes corresponding to cdf values of
0.02 and 0.98. In our model, the coefficient k is:
k ¼
30mm
a98   a2
: ðB:2Þ
In an optimally gated measurement, data are processed
when s is between the limits L and U. Relative to the lowest
observed s position, the average s value is:
savg ¼
R U
L ds   s   hðsÞ
R U
L ds   hðsÞ
; ðB:3Þ
and the variance is:
s2
s ¼
R U
L ds   s   savg
   2   hðsÞ
R U
L ds   hðsÞ
: ðB:4Þ
During the OG measurement period, the variance in z
positions is:
s2
respiratory ¼ k2s2
s; ðB:5Þ
This can be used to estimate PET image resolution when
OG is used. In the absence of motion, the PET image is
characterized by a full-width at half-maximum (FWHM)
resolution parameter due to system resolution and post-
reconstruction filtering. With system resolution of about
4 mm and post-reconstruction filtering of 5 mm used in our
clinical work, that parameter is 6.4 mm. It is reasonable to
invoke the central limit theorem and convert variances to
FWHM in a gaussian model:
PETFWHM ¼ 2:355  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2
recon þ s2
respiration
q
: ðB:6Þ
Since this resolution figure of merit depends on the
patient’s breathing pattern and on the OG sensitivity
parameter, we applied (Eq. B.6) to the respiration curves
of all patients in our study, and varied the sensitivity from
5% to 95%. Figure 8a indicates the lower and upper edges
Fig. 8 a Histogram of a patient’s respiration amplitudes. The
amplitude ranges found by the OG algorithm for sensitivities from
5% to 95% are shown in blue. It was assumed that tumour excursion is
30 mm (black arrow). The 35% sensitivity value (red arrow) was used
in this research. b For each of the 26 patients in our study, the PET
FWHM resolution modelled by Eq. B.6 is plotted as a function of OG
sensitivity (red arrow 35% sensitivity)
Eur J Nucl Med Mol Imaging (2011) 38:843–855 853of the optimal windows for each sensitivity parameter.
Figure 8b shows the resolution curves for all patients.
When the OG sensitivity is 35%, the resolution of the
OG method (7.6 mm average over all patients) is only a
little larger than the resolution without OG (6.4 mm). This
is true for all patients, and it is true even though we
assumed an unusually large tumour motion (30 mm). If we
assumed a more typical tumour motion of 15 mm, the
resolution would be 6.7 mm.
In this sense, our method is optimal. One can use
sensitivity values much smaller than 35%, but this would be
at the cost of lower statistics with little advantage in
resolution. One can use larger sensitivity values, making
the image less noisy, but the resolution may be significantly
worse, up to 20 mm in some patients. The 35% setting
strikes a balance between resolution and noise.
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